3,252 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 586 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,252
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JP Morgan Chase
JP Morgan Chase
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
676
$10M
677
$10M
678
$10M
679
$10M
680
$9.98M
681
$9.96M
682
$9.96M
683
$9.96M
684
$9.92M
685
$9.92M
686
$9.88M
687
$9.87M
688
$9.83M
689
$9.79M
690
$9.79M
691
$9.78M
692
$9.78M
693
$9.77M
694
$9.77M
695
$9.73M
696
$9.69M
697
$9.68M
698
$9.66M
699
$9.65M
700
$9.65M